GlaxoSmithKline, Valeant Submits Response To FDA For Ezogabine

18-04-2011 Wall Street JournalComments (0)


LN), a pharmaceutical company, said Monday it and Valeant Pharmaceuticals International Inc. (VRX) have submitted on April 15 the response to the US Food and Drug Administration, or FDA Complete Response letter received for the New Drug Application for ...

Read more on Wall Street Journal

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top